New3

Angiogenesis

5-alpha Reductase ALK Bcr-Abl BTK EGFR FAK FLT3 HER-2 HIF Src Syk VDA VEGFR
Anti-infection

Antibiotic Arenavirus Bacterial CMV EBV Enterovirus Filovirus Fungal Gli HBV HCV HCV Protease HIV HSV Influenza Virus Parasite RABV Reverse Transcriptase RSV SARS-CoV TMV Virus Protease
Apoptosis

Apoptosis ASK Bcl-2 Caspase c-Myc c-RET Cytohesin DAPK Ferroptosis FKBP IAP Mdm2 p53 PD-1 PD-L1 PERK PKD Ras RIP kinase ROS Survivin Thymidylate Synthase TNF Receptor TNFa TRADD
Autophagy

Autophagy LRRK2 Mitophagy OGA ULK
Cell Cycle

Antifolate APC Aurora Kinase BMI-1 CDK Chk c-Myc Eukaryotic Initiation Factor G-quadruplex HDAC HSP Kinesin LIMK Mad2 Microtubule(Tubulin) Mps1 Nucleoside Antimetabolite/Analog Nur77 p21 PAK PERK PFKFB PLK PPAR Ras Rho ROCK SRPK TOPK Topoisomerase Wee1
Cytoskeletal Signaling

Arp2 3 Complex Bcr-Abl Cardiac Myosin Dynamin Gap Junction Protein HSP Integrin Kinesin Microtubule Associated MLCK Myosin PAK TACC3 Wntbeta-catenin
DNA Damage

ATM(ATR) CRISPR(Cas9) DNA alkylator DNA Stain DNA(RNA) Synthesis GAK HDAC HSP Nucleoside Antimetabolite(Analog) OGG1 p97 PARG PARP RAD51 RNR Sirtuin SMN Telomerase Topoisomerase
Endocrinology & Hormones

5-alpha Reductase ACE Adrenergic Receptor Androgen Receptor Aromatase Estrogenprogestogen Receptor Glucocorticoid Receptor GPR Mineralocorticoid Receptor RAAS THR TSH Receptor
Epigenetics

AMPK Aurora Kinase DNA Methyltransferase Epigenetic Reader Domain EZH1 2 HDAC HIF Histone Acetyltransferase Histone Demethylase Histone Methyltransferase JAK MAT MicroRNA MLL Pim PKC Protein Arginine Deiminase Sirtuin Small Interfering RNA (siRNA) SMYD
GPCR & G Protein

5-HT Receptor Adenosine Receptor Adenylate Cyclase Adrenergic Receptor Angiotensin Receptor APJ Bombesin Receptor Bradykinin Receptor cAMP Cannabinoid Receptor CaSR CCK receptor CCR CGRP Receptor CRFR CXCR Dopamine Receptor EBI2 Endothelin Receptor Formyl Peptide Receptor Free Fatty Acid Receptor G protein-coupled Bile Acid Receptor GCGR GHSR GLP Receptor Glucagon Receptor GnRH Receptor GPCR19 GPR GPR109A Guanylate Cyclase Hedgehog(Smoothened) ROCK Histamine Receptor ICMT Leukotriene Receptor LPA Receptor LPL Receptor LTR mAChR Melanocortin Receptor Melatonin Receptor mGluR Motilin Receptor MRGPR MT Receptor Neurokinin Receptor Neuropeptide Y Receptor Neurotensin Receptor NPY receptor Opioid Receptor OX Receptor Oxytocin Receptor P2Y Receptor PAFR PAR PKD PKG Prostaglandin Receptor Ras RGS Protein S1P Receptor SGLT Sigma Receptor Somatostatin Receptor TAAR TSH Receptor Urotensin Receptor Vasopressin Receptor

+MORE

New3

New3 related products

Cat No.	Product Name	CAS No.	Product Description
V43016	α-D-Glucopyranosyl 1-phosphate-13C dicyclohexylamine	478518-99-9	α-D-Glucopyranosyl 1-phosphate-13C (dicyclohexylamine, monohydrate) is 13C (carbon 13)-labeled α-D-Glucopyranosyl 1-phosphate.
V45600	α-Glucosidase-IN-10	2586282-68-8	α-Glucosidase-IN-10 (compound 13) is a potent α-glucosidase inhibitor (antagonist) with IC50 of 92.7 μM.
V43742	α-Glucosidase-IN-11	2411744-76-6	α-Glucosidase-IN-11 is a highly permeable/penetrable competitive α-glucosidase (α-glucosidase) inhibitor (antagonist) with IC50 of 0.56 μM.
V43951	α-Glucosidase-IN-12		α-Glucosidase-IN-12 (compound 14) is a potent α-glucosidase inhibitor (antagonist) with IC50 of 10.20 μM.
V44050	α-Glucosidase-IN-13		α-Glucosidase-IN-13 (Compound 8) is an α-glucosidase inhibitor (antagonist) with IC50 of 5.69 μM.
V44004	α-Glucosidase-IN-14		α-Glucosidase-IN-14 (compound 5) is a potent α-glucosidase inhibitor (antagonist) with IC50 of 5.22 μM.
V43591	α-Glucosidase-IN-15		α-Glucosidase-IN-15 (Compound 14B) is a potent, orally bioactive α-glucosidase inhibitor (antagonist) with IC50 of 3.34 μM.
V43561	α-Glucosidase-IN-16	1606142-34-0	α-Glucosidase-IN-16 is a potent and orally bioactive α-glucosidase inhibitor (antagonist) with IC50 of 3.28 μM.
V43542	α-Glucosidase-IN-17		α-Glucosidase-IN-17 (Compound 12B) is a potent, orally bioactive α-glucosidase inhibitor (antagonist) with IC50 of 3.79 μM.
V43555	α-Glucosidase-IN-18		α-Glucosidase-IN-18 (7B) is an orally bioactive α-glucosidase inhibitor (antagonist) with IC50 of 3.96 μM.
V43338	α-Glucosidase-IN-19		α-Glucosidase-IN-19 (Compound 6B) is an orally bioavailable α-glucosidase inhibitor (antagonist) with IC50 of 3.63 μM.
V48966	α-Glucosidase-IN-2	2699784-18-2	α-Glucosidase-IN-2 (compound 5d) is a potent α-Glucosidase inhibitor (antagonist) with IC50 of 9.48 μM.
V43315	α-Glucosidase-IN-20	420809-56-9	α-Glucosidase-IN-20 (Compound 3B) is an orally bioavailable α-glucosidase inhibitor (antagonist) with IC50 of 3.01 μM.
V43574	α-Glucosidase-IN-21	321686-01-5	α-Glucosidase-IN-21 (Compound 2B) is an orally bioavailable α-glucosidase inhibitor (antagonist) with IC50 of 2.62 μM.
V48962	α-Glucosidase-IN-3	2758286-48-3	α-Glucosidase-IN-3 is an oleanolic acid oxime ester analogue targeting α-glucosidase (IC50=0.35 µM) and α-amylase.
V47586	α-Glucosidase-IN-4	2410538-67-7	α-Glucosidase-IN-4 is a reversible mixed α-glucosidase inhibitor (antagonist) with IC50 of 12.98 μM, Ki of 27.02 μM, and KiS of 13.65 μM.
V46270	α-Glucosidase-IN-5	111316-33-7	α-Glucosidase-IN-5 (compound 8) is a potent α-glucosidase inhibitor (antagonist) with IC50 of 57.9 µM.
V46130	α-Glucosidase-IN-6	2497685-29-5	α-Glucosidase-IN-6 (compound 18) is a competitive α-glucosidase inhibitor (antagonist) with IC50 of 5.69 µM.
V46284	α-Glucosidase-IN-7		α-Glucosidase-IN-7 is a noncompetitive α-glucosidase (α-glucosidase) inhibitor (antagonist) with IC50 of 18.9 µM.
V46035	α-Glucosidase-IN-8	2448345-96-6	α-Glucosidase-IN-8 (Compound 4k) is a competitive α-glucosidase inhibitor (antagonist) with IC50 of 0.18 µg/mL.